Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-132938
Filing Date
2020-12-07
Accepted
2020-12-07 17:48:24
Documents
1
Period of Report
2020-12-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2037869-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2037869-5_4seq1.xml 4 4016
  Complete submission text file 0001104659-20-132938.txt   5470
Mailing Address ONE BAXTER PARKWAY DEERFIELD IL 60015
Business Address
Oesterle Stephen N. (Reporting) CIK: 0001174532 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39746 | Film No.: 201373700

Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Issuer) CIK: 0001821323 (see all company filings)

EIN.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations